H.C.
The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …
Agile Therapeutics Inc (NASDAQ:AGRX) investors are in a scramble today after the firm released top-line data from its SECURE Phase 3 study of …
Sunedison Inc (NYSE:SUNE) is up over 4% in mid-day trading following the company’s announcement that it would extinguish $336 million in debt. In …
In a research report released today, William Blair analyst Tim Lugo reaffirmed an Outperform rating on Agile Therapeutics (NASDAQ:AGRX) with an $18 price …
In a research note released today, Janney Capital analyst Kimberly Lee reiterated a Buy rating on Agile Therapeutics (NASDAQ:AGRX) with an $18 fair value …
Janney Capital analyst Kimberly Lee is out today with an interesting call initiating Agile Therapeutics, Inc. (AGRX) with a Buy rating and $18 fair …